Overview
Adams-Oliver syndrome (AOS) is a rare congenital disorder characterized by the combination of aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects. Aplasia cutis congenita refers to localized areas of absent skin, most commonly on the vertex of the scalp, which may extend to involve the underlying bone (skull defect). The limb defects are highly variable and can range from mild findings such as short or absent distal phalanges and nail abnormalities to more severe truncation defects of the hands and feet. The condition is present at birth, and the severity of features can vary considerably even within the same family. In addition to the hallmark scalp and limb findings, Adams-Oliver syndrome can affect other body systems. Cardiovascular malformations, including congenital heart defects such as ventricular septal defects, tetralogy of Fallot, and other structural anomalies, occur in a significant proportion of affected individuals. Cutis marmorata telangiectatica congenita (CMTC), a vascular skin condition causing a marbled appearance of the skin, is also frequently observed. Some patients may develop pulmonary hypertension, which can be a serious complication. Less commonly, central nervous system abnormalities, including developmental delay and structural brain malformations, have been reported. Adams-Oliver syndrome is genetically heterogeneous. Both autosomal dominant and autosomal recessive forms have been identified. Autosomal dominant forms are associated with pathogenic variants in genes such as ARHGAP31, DLL4, NOTCH1, and RBPJ, while autosomal recessive forms are linked to DOCK6 and EOGT. Treatment is supportive and symptom-based. Scalp defects may require wound care and sometimes surgical intervention, including skin grafting or bone reconstruction. Limb anomalies may benefit from orthopedic management or prosthetics. Cardiac defects and pulmonary hypertension require appropriate medical or surgical management. Regular monitoring by a multidisciplinary team including dermatology, cardiology, orthopedics, and genetics is recommended.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsIdoven 1903 S.L.
University of Central Florida — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Adams-Oliver syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Adams-Oliver syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Adams-Oliver syndrome.
Community
No community posts yet. Be the first to share your experience with Adams-Oliver syndrome.
Start the conversation →Latest news about Adams-Oliver syndrome
Disease timeline:
New recruiting trial: Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ
A new clinical trial is recruiting patients for Adams-Oliver syndrome
New recruiting trial: Motor Imagery for Treatment Enhancement and Efficacy in Persons With Apraxia of Speech
A new clinical trial is recruiting patients for Adams-Oliver syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Adams-Oliver syndrome
What is Adams-Oliver syndrome?
Adams-Oliver syndrome (AOS) is a rare congenital disorder characterized by the combination of aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects. Aplasia cutis congenita refers to localized areas of absent skin, most commonly on the vertex of the scalp, which may extend to involve the underlying bone (skull defect). The limb defects are highly variable and can range from mild findings such as short or absent distal phalanges and nail abnormalities to more severe truncation defects of the hands and feet. The condition is present at birth, and the severity of feature
At what age does Adams-Oliver syndrome typically begin?
Typical onset of Adams-Oliver syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Adams-Oliver syndrome?
1 specialists and care centers treating Adams-Oliver syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.